Related Experiment Video
Updated: Apr 21, 2026
11:36
Glycan Node Analysis: A Bottom-up Approach to Glycomics
Published on: May 22, 2016
10.1K
Hyperglycemia as a risk factor for cancer progression
Tae Young Ryu1, Jiyoung Park1, Philipp E Scherer2
1Department of Biological Sciences, Ulsan National Institute of Science and Technology School of Life Sciences, Ulsan, Korea.
Diabetes & Metabolism Journal
|October 29, 2014
Summary
Diabetes increases cancer risk and mortality, particularly type 2 diabetes. Hyperglycemia, hyperinsulinemia, and inflammation may drive tumor growth, but molecular links require further study for effective patient treatment.
Area of Science:
- Endocrinology and Oncology
- Metabolic Syndrome and Cancer Biology
Background:
- Global rise in diabetes mellitus correlates with increased incidence of associated diseases, including various cancers.
- Diabetic patients exhibit higher prevalence and mortality rates for cancers like pancreatic, liver, breast, and reproductive cancers.
- Type 2 diabetes, in particular, shows a suggested association with cancer incidence and progression.
Purpose of the Study:
- To explore the link between hyperglycemia and cancer risk.
- To discuss the potential molecular mechanisms connecting diabetes and cancer.
- To outline treatment implications for diabetic cancer patients.
Main Methods:
- Review of current scientific literature on diabetes, hyperglycemia, and cancer.
- Analysis of proposed molecular pathways, including hyperinsulinemia and chronic inflammation.
- Discussion of clinical implications for managing diabetic patients with cancer.
Main Results:
- Hyperglycemia, hyperinsulinemia, and chronic inflammation are common in diabetes and may promote tumor growth.
- Chronic hyperglycemic episodes are implicated as mediators of increased tumor cell proliferation.
- The precise molecular mechanisms underlying the diabetes-cancer association are still under investigation.
Conclusions:
- A significant association exists between diabetes, especially type 2, and increased cancer risk and progression.
- Understanding the role of hyperglycemia in cancer development is crucial for patient care.
- Further research into molecular mechanisms is needed to guide therapeutic strategies for diabetic cancer patients.
More Related Videos
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
12.5K
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
2.1K
Related Concept Videos
01:29Hyperglycemia
2
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
2
01:15Hypoglycemia and Glucagon
1.2K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.2K
01:19Psychoneuroimmunology: Diabetes and Cancer
520
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
520
01:26Hypoglycemia
5
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
5
01:24Type II Diabetes II: Pathophysiology
6
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
6
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K